Found 7 matching trials
Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal
NAThis research study is to compare the radiopharmacokinetics of I-124 to the...
Location
Washington Hospital Center
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy
PHASE2Progressive and metastatic thyroid cancer patients, who no longer respond t...
Location
National University Hospital
Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)
NAThis is a single-centre open label phase II study evaluating the effect of ...
Location
Leiden University Medical Center
A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
PHASE2This prospective, multi-centre, open label, non-randomised phase II trial a...
Location
Royal North Shore Hospital
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
PHASE1One of the most effective treatments for metastases from thyroid cancer is ...
Location
Memorial Sloan Kettering Cancer Center
Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)
NAThis research study is to compare the radiopharmacokinetics of I-124 to the...
Location
Washington Hospital Center
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
PHASE2This phase II trial studies how well trametinib works in increasing tumoral...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center